Silver-Coated TPLO Plates: What the Evidence Shows, and Where the Dose Limit Sits
A note on the date before anything else
This study was published in the International Journal of Molecular Sciences in April 2023, in volume 24, issue 9. It is not a 2026 finding. It keeps resurfacing in supplier conversations because it is one of the few studies that tested an antimicrobial coating on actual TPLO implants in live dogs. Presenting it as new would be inaccurate; presenting it as settled would be worse.
Clinical disclaimer
Procedure choice is case-specific and must be made by the attending veterinary surgeon. This article summarizes published evidence and inventory implications; it is not an outcome guarantee and does not replace peer-reviewed literature, training courses or product instructions for use.
Why the question matters
Implant-associated infection is a low-frequency, high-consequence event in veterinary orthopaedics. When it happens, the cost is not only a second surgery. It is also owner trust, referral relationships and, for a distributor, a product line that suddenly looks risky. Any coating that reduces bacterial adhesion without harming bone healing is therefore commercially interesting.
The question is whether the evidence supports the claims that get made on the box.
What was tested
The authors coated TiAlV TPLO implants with hybrid layers containing silver, copper and zinc nanoparticles, applied by a sol-gel dip-coating process. The work proceeded in three layers:
- In vitro bactericidal testing against Gram-positive bacteria (Staphylococcus aureus, Enterococcus faecalis), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and a pathogenic yeast (Candida albicans).
- Cytotoxicity testing on MG-63 and Saos human osteosarcoma cell lines, looking at adhesion, proliferation, viability and differentiation.
- In vivo implantation in six canine patients using implants coated with 0.5% silver nanoparticles, followed for three months with radiography and histopathology.
The results, including the uncomfortable part
Silver produced the strongest bactericidal effect of the three metals. That is the headline.
The less-quoted finding is the dose response. Toxicity rose with increasing metallic nanoparticle concentration, and the authors describe the effect as pronounced once silver exceeded 1 mol%. Their conclusion states that silver above 1% may be cytotoxic and can produce cell necrosis and apoptosis.
In other words, the same additive that kills bacteria will damage osteoblasts if the concentration is pushed too high. The window is narrow.
At 0.5%, the coated implants were implanted in six dogs. The reported outcomes were:
- No postoperative deviations during follow-up.
- All dogs returned to full fitness.
- Postoperative tibial plateau angles were below 5°.
- Good biocompatibility and accelerated bone healing, with no antibiotic administration reported.
- The coating also protected the implant surface against corrosion and surgical scratches.
What the study does not show
This is where a careful reader should slow down.
There was no control group. The authors state that future work will include a comparison group receiving uncoated implants. Without that comparison, claims about faster healing and reduced recovery time rest on historical or expected performance, not on a concurrent control.
The sample was six dogs. That is enough to show the coating did not cause obvious harm. It is not enough to estimate an infection rate, because the study was not powered or designed to measure one.
Cytotoxicity was assessed on human osteosarcoma cell lines, not canine osteoblasts. Species differences in response to silver nanoparticles are not resolved by this design.
And the coating is not a marketed product category with published lot-to-lot validation. It is a research construct.
The dose window in one table
| Silver concentration | Reported effect |
|---|---|
| 0.5% | Selected for in vivo use; no postoperative deviations in six dogs; bone healing reported as accelerated |
| Above 1 mol% | Pronounced cytotoxic effect; necrosis and apoptosis described |
| Increasing concentration generally | Bactericidal efficacy rises, toxicity also rises |
Five questions to ask any supplier selling "antimicrobial" implants
- Which antimicrobial agent is used, at what concentration, and is the concentration disclosed in writing?
- Was cytotoxicity tested, on which cell type, and at which dilutions?
- Was there a control group, and how many animals were followed?
- Is coating adhesion, thickness and release validated lot to lot, or only in a research batch?
- Does the coating survive the sterilization method used for the finished product?
A supplier who cannot answer these is selling a concept, not a validated feature.
Do silver-coated TPLO plates prevent infection?
The 2023 study showed strong in vitro bactericidal activity and no postoperative deviations in six dogs. It did not measure infection rates against a control group, so "prevent" is stronger than the evidence supports.
Why is 1% the relevant threshold?
The authors observed pronounced cytotoxicity above 1 mol% silver, including necrosis and apoptosis in cell culture. Below that, at 0.5%, the coating was used in vivo without reported adverse events.
Is a silver coating available as a standard product?
Not as a validated, widely marketed category with published lot-level data. The published work describes a research coating applied to commercially available implant geometry.
Does the coating interfere with bone healing?
The authors report the opposite at 0.5%: accelerated healing and good biocompatibility. That claim lacks a concurrent control group, so it should be treated as preliminary.
Should distributors ask for coating data?
Yes. Ask for concentration, cell model, animal number, control design, sterilization compatibility and lot validation. Those six items separate a feature from a story.
What we supply
Shuangyang Medical Instrument supplies TPLO plate systems, locking and non-locking plates, screws and procedure instrument sets for veterinary orthopaedic use. Our standard product line is uncoated; we do not claim an antimicrobial coating. If your clinic or distribution business is evaluating coated implants, the checklist above is a practical way to compare suppliers on evidence rather than wording.
References and sources
Evaluating coated or standard TPLO implants?
Send us your case requirements — our technical team can walk through materials, configurations, sterilization and MOQ for our standard uncoated TPLO and plate range.
Request a Quote